The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery

Sponsor
Robert Kramer, MD (Other)
Overall Status
Completed
CT.gov ID
NCT00821522
Collaborator
MaineHealth (Other)
120
1
2
17.9
6.7

Study Details

Study Description

Brief Summary

Acute kidney injury is associated with cardiopulmonary bypass during heart surgery and its pathogenesis is similar to that of ischemia-reperfusion injury. Remote ischemic preconditioning attenuates myocardial ischemia-reperfusion injury in patients undergoing coronary bypass surgery. The investigators hypothesize that such preconditioning reduces the incidence of acute kidney injury associated with cardiopulmonary bypass.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Remote Ischemic Preconditioning
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery
Study Start Date :
Nov 1, 2008
Actual Primary Completion Date :
Mar 1, 2010
Actual Study Completion Date :
May 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Preconditioning

Procedure: Remote Ischemic Preconditioning
Three 5-minute intervals of leg ischemia induced by tourniquet inflation, prior to initiation of cardiopulmonary bypass.

No Intervention: Control

Standard clinical management during cardiac surgery.

Outcome Measures

Primary Outcome Measures

  1. Incidence of acute kidney injury, after surgery, as defined by elevation in serum creatinine greater than or equal to 0.3 mg/dl. [48 hours after surgery.]

Secondary Outcome Measures

  1. Oliguria. [12 hours after surgery.]

  2. Incidence of acute kidney injury as defined by post-operative elevation in NGAL. [3 hours after cardiopulmonary bypass.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient undergoing heart surgery on cardiopulmonary bypass.
Exclusion Criteria:
  • Known peripheral vascular disease of the lower extremities associated with active skin necrosis or infection.

  • End-stage renal disease.

  • Inability to give informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maine Medical Center Portland Maine United States 04102

Sponsors and Collaborators

  • Robert Kramer, MD
  • MaineHealth

Investigators

  • Principal Investigator: Robert F Zimmerman, MD, MaineHealth

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Robert Kramer, MD, Thoracic Surgery, MD, MaineHealth
ClinicalTrials.gov Identifier:
NCT00821522
Other Study ID Numbers:
  • 3401
First Posted:
Jan 13, 2009
Last Update Posted:
Nov 17, 2021
Last Verified:
Nov 1, 2021

Study Results

No Results Posted as of Nov 17, 2021